ArticleEJHaem2025

Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety.

Roberta Dunn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.